key: cord-0951937-c5g04smb
authors: Gravningen, Kirsten; Henriksen, Stian; Hungnes, Olav; Svendsen, Kristian; MacDonald, Emily; Schirmer, Henrik; Stene-Johansen, Kathrine; Simonsen, Gunnar Skov; Kacelnik, Oliver; Elstrøm, Petter; Bragstad, Karoline; Rinaldo, Christine Hanssen
title: Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway
date: 2022-02-18
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.02.025
sha: edddabe445420ae01c16e5c36ec03c13118cb854
doc_id: 951937
cord_uid: c5g04smb

Objective : To improve understanding of SARS-CoV-2-transmission and prevention measures on cruise ships, we investigated a Norwegian cruise ship outbreak in July-August 2020 using a multidisciplinary approach, following a rapid outbreak-response launched by local and national health-authorities. Methods : We conducted a cross-sectional study among crew members using epidemiological data and results from SARS-CoV-2-PCR of nasopharynx-oropharynx samples, antibody analyses of blood-samples, and whole-genome sequencing. Results : We included 114 multinational crew members (71% participation), median age 36 years and 69% men. Attack rate was 33%; 32 of 37 outbreak-cases were seropositive 5-10 days post-PCR. One PCR-negative participant was seropositive, suggesting prior infection. Network-analysis showed clusters based on common exposures, including embarkation date, nationality, sharing cabin with an infected cabin-mate (AOR 3.27 (95%CI 0.97-11.07, p=0.057), and specific workplaces (mechanical operations: 9.17 (1.82-45.78), catering: 6.11 (1.83-20.38)). Breaches in testing, quarantine and isolation practices before/during expeditions were reported. Whole-genome sequencing revealed lineage B.1.36, previously identified in Asia. Despite extensive sequencing, continued transmission of B.1.36 in Norway was not detected. Conclusions : Our findings confirm high risk of SARS-CoV-2-transmission on cruise ships related to workplace and cabin-type and show that continued community-transmission after the outbreak could be stopped by implementing immediate infection control measures at the final destination.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported from Wuhan, China in 2019, leading to outbreaks of coronavirus disease and rapid spread worldwide. Cruise ships are ideal incubators for respiratory viruses due to crowded places, close-contact settings, and confined and enclosed spaces (the three C's) (WHO, 2021) .

Consequently, a number of SARS-CoV-2 outbreaks have occurred on cruise ships causing considerable morbidity and mortality (Expert Taskforce for the COVID-19 Cruise Ship Outbreak, 2020 , Kordsmeyer et al., 2021 . Cruise operators need to ensure that cruises do not pose unacceptable health risks to passengers, crew and the general public (ECDC, 2021) .

Early recognition and an effective outbreak management strategy is crucial to control SARS-CoV-2 transmission on board (Kordsmeyer et al., 2021 , Walker et al., 2021 . To our knowledge, this is the first study of a SARS-CoV-2 outbreak in northern European waters on a cruise ship registered in a Nordic country.

In June 2020, MS Roald Amundsen became the first cruise ship to return to service in Norway following a three-month suspension due to the pandemic, after having been in storage in a small coastal municipality with multinational crew on board. The ship had recently updated but not fully implemented outbreak prevention, control and response plans (Wiersholm AS and DNV GL SA Law Firm, 2020) . At the time, the national incidence of COVID-19 was low (3.7 cases/100,000 population/14 days), and no cases were reported from this municipality to the Norwegian Institute of Public Health (NIPH). The ship had a total capacity of 528 passengers. From 6-17 July 2020, approximately 90 crew members recruited through a foreign staffing company arrived in Norway, primarily from the Philippines. Before starting service, they had to provide COVID-19 certificates confirming negative results for tests taken 3-4 days prior to departure but were not tested in Norway before boarding the ship.

They underwent 10-days initial restrictions on board including social distancing, respiratory and hand hygiene measures, and isolation in a single cabin if any symptoms developed.

However, they were allowed to work during quarantine, except those employed in the kitchen.

Passengers and crew members had cabins on separate decks. Single or twin cabins were assigned to the staff based on job and rank; however, some were quarantined in twin cabins together with staff with an earlier embarkation date.

MS Roald Amundsen completed two one-week voyages from Tromsø and around the Svalbard archipelago at 75° north and back; Expedition 1, 17-24 July, included 210 passengers and 160 crew, and Expedition 2, 24-31 July, included 181 passengers and 160 crew. Most passengers were Norwegian citizens while 5% were from other European countries. Most crew members attended both expeditions.

On 26 July, two days after returning home from Expedition 1, a passenger developed symptoms and had a positive SARS-CoV-2 test result two days later. The timeline was consistent with probable exposure on board (Lauer et al., 2020) . On 29 July, the local municipal medical officer notified NIPH about the case who then immediately contacted the ship and recommended alerting and testing of passengers but no action was taken. During Expedition 2, several symptomatic crew members were reported unable to work but were not tested nor isolated.

After finishing Expedition 2, the ship arrived back in Tromsø in the morning of 31 July. At midday, NIPH was alerted by the Tromsø municipal chief medical officer that four sick crew members had been hospitalized and subsequently diagnosed with COVID-19. By then, all passengers had left the ship. An outbreak response was immediately launched by Tromsø municipality with support from the NIPH and Norwegian Directorate of Health. The objectives were to determine the origin and extent of the outbreak and implement infections control measures to prevent further spread in Norway.

On 31 July and during the following days, all passengers and crew on both expeditions had a nasopharynx-oropharynx swab taken, either in Tromsø or at their current location, which was tested by real-time polymerase chain reaction (PCR) for SARS-CoV-2. All close contacts of cases on both expeditions were traced and tested. After 31 July, crew member cases were isolated in single cabins or at the hospital, while those who tested negative were quarantined on board or in hotels in Tromsø.

Attack rate among crewmembers was 25.2% (42 of 167) compared to 7.2% (28 of 391) among passengers, with an increase in affected passengers from 1.4% on Expedition 1 to 13.8% on Expedition 2. All crew members who tested positive had attended both expeditions.

Reported dates for symptom onset for crew members ranged from July 6-August 11 and for passengers from July 26-August 8. Ten crew members were hospitalized due to severe illness (no fatalities).

Following the outbreak response, we conducted a study to find when and how the virus was introduced and to examine risk factors for transmission on board. To do so, we examined samples and exposure data collected from the crew members while they were in quarantine or isolation in Tromsø, as they had a significantly higher attack rate than the passengers and were still in one geographic area. As only a quarter of the crew was infected, we also aimed to assess if the non-infected crewmembers were protected by immunity from earlier infections.

We conducted a cross-sectional study among the crew members present in Tromsø from 9-11 August 2020. The study coordinator gave a video-streamed information talk to all crewmembers in quarantine or isolation on the ship 9 August, which they shared in real time with their colleagues staying in hotels or in the hospital. Afterwards, the attendees received written study information and consent forms.

From 10-11 August, five to 10 days after nasopharynx-oropharynx sampling (NOPS) from 31

July-6 August, the coordinator and a laboratory team collected signed consent forms and venous blood samples from crew members agreeing to participate. Participants staying in hotels or in the hospital were sampled on-site. A case was defined as a participant having attended Expedition 2 with a positive SARS-CoV-2 PCR result.

The NIPH received crew and passenger lists from the ship including data on sex, age, country of origin, embarkation date, workplace, cabin number and type, symptom onset date, clinical symptoms, test date and results that were included in the NIPH outbreak registry and used in our study. Type of work was categorized as administrative, passenger services, outdoor work, mechanical operations, and catering occupations (Table 1) .

NOPS were analyzed with a SARS-CoV-2 real-time reverse transcription PCR test with primers and probe in the E-gene (Corman et al., 2020) , which was considered positive when the cycle threshold (Ct) value was ≤37. Plasma was tested for SARS-CoV-2 antibodies with the Abbott Architect SARS-CoV-2 IgG and IgM assays, detecting anti-nucleocapsid antibodies, and with the Liaison SARS-CoV-2 S1/S2 IgG and IgM assays, detecting antispike antibodies (Supplementary table 1) . Of note, IgG antibodies against spike is a correlate of neutralizing activity (Dispinseri et al., 2021) . To avoid unspecific results, only samples positive in at least two different assays were considered seropositive. For selected samples, SARS-CoV-2 IgG was additionally analysed by immunofluorescence staining of SARS-CoV-2 infected Vero cells (Henriksen et al., 2020) .

We performed whole-genome sequencing (WGS) of SARS-CoV-2 using the Artic Network nCoV-2019 V3 protocol (Corona Methods Development Community, 2020) and an Illumina MiSeq sequencer, with some supplementary genome sequences obtained using the Swift Amplicon SARS-CoV-2 Panel (Swift Bioscience, Ann Arbor, USA) on Illumina NovoSeq at the Norwegian Sequencing Centre. The resulting sequences were assembled into consensus genome sequences using pipelines available on GitHub (pipelines for the Artic data: https://github.com/folkehelseinstituttet/fhi-ncov-seq-pipelines). The most similar sequences in the GISAID database EpiCoV were identified using BLAST and included in phylogenetic analysis by Neighbor-Joining of Maximum Composite Likelihood distances using the MEGA X software (Kumar et al., 2018) .

We linked outbreak registry data to laboratory data from the University Hospital of North Norway (UNN) and WGS results from the NIPH. We used Stata v16.1 (StataCorp LLC, Texas, US) for multivariable logistic regression analysis with outcome-variable SARS-CoV-2 test-result and calculated adjusted odds ratios (AORs) with 95% confidence intervals (CIs).

Variables with p-value >0.1 were included in the model. We considered two-sided p-values <0.05 statistically significant. Collinearity was not a problem with variance inflation factor <2.0 for all variables. Interaction was assessed by including cross-product terms between all independent variables and gender. There was no statistically significant interaction in the full model. We used non-parametric tests to compare participants' IgG titers in different embarkation periods and to compare Ct values between IgG-positive and IgG-negative participants. The descriptive network analysis was conducted using Stata, while the network was visualized and modularity determined using Gephi 0.9.2, an open-source free software for network visualization and exploration (https://gephi.org). The network was weighted by number of shared characteristics using the following four: grouped date of embarkation, sharing a cabin, workplace and country of origin (weight 0 to 4).

In total, 71% (114 of 160) of eligible crewmembers with median age 36.4 years participated in the study, of whom 69% were men, 29% were Norwegians/Europeans, and 71% Filipinos (Table 1) . Median number of days on board prior to PCR-testing was 24 (IQR 18-37). Most Norwegian/European participants (88%, n=29) had single cabins compared to 38% (n=31, p<0.001) of Filipino participants. Fifty (62%) Filipino participants shared a twin cabin with a fellow citizen while only four (12%, p<0.001) Norwegian/European participants did so.

The attack rate among crew member participants was 32.5% (37/114), similar to that of the entire crew (25.8%, p=0.182). The distribution of cases by date and symptom onset shows a slowly increasing outbreak with a sharp peak on 31 July, and then decreasing incidence ( Figure 1 ). Participants confirmed PCR positive had mean Ct value 24.9 (range 15.4-36.8).

Respiratory infection symptoms were reported by 25 (68%) cases, including six additionally having lost sense of smell and taste and two reporting gastroenteritis. Nine had "other" or unknown symptoms, and three were asymptomatic (Table 2) . SARS-CoV-2 spread among the participants in most workplaces on board. The first cases retrospectively reporting symptom onset between 20-22 July, worked in catering occupations and mechanical operations (Figure 1 ). Nine days later, symptoms among administrative and passenger service staff were reported. No cases were identified among participants working on deck, with electricity and carpentry, or with medical and spa services.

The attack rate was higher among Filipino participants (41%) than among those from Norway/Europe (12%, p=0.006) ( Table 3 ). In multivariable analyses, being a case was associated with working with mechanical operations (AOR 8.26, 95% CI 1.54-44.16) and catering occupations (6.06, 1.78-20.67). Sharing twin cabin with an infected cabin mate was strongly associated with being a case in crude analysis (OR 7.20, ) but was attenuated to 3.27 (0.97-11.07) in the full model. Mean serial interval between symptom onset in twin cabins with both persons infected was 4.3 days (range 1-8 days).

The network analysis displayed four distinct clusters ( Figure 2 ). The purple cluster (n=42) had attack rate 50% of which 71% had catering occupations, all had embarkation date 6-8 July, and most were Filipinos (98%) and stayed in twin cabins (76%) (Figure 2 , Table 4 ). Two clusters (green, n=31 and blue, n=10) had an attack rate similar to that of the study population as a whole and most participants were Filipino. The orange (n=31) had attack rate 10%, well below the study population, and most participants were Norwegian or European (97%), had outdoor work (55%), single cabin (90%) and late embarkation (84%). Cases were neither more central in the network nor had more links than non-cases.

Antibody analysis of the 37 outbreak-cases demonstrated SARS-CoV-2 seropositivity in 32 (87%), confirming their COVID-19 diagnosis (Figure 3 ). Except one seropositive case with only IgG and five cases with only IgM, all seropositive cases had both IgM and IgG antibodies. The quantitative anti-spike IgG assay revealed antibody titers from 18.5-166 AU/ml (mean value 70 AU/ml). There was a non-significant increase in antibody titers with increasing time after reported symptom onset (p=0.092), and only samples taken more than 7 days after symptom start had titers above 100 AU/ml (Figure 4) . Median Ct value of NOPS was 7.9 Ct values lower in the 10 IgG negative compared to the 27 IgG positive cases (p=0.130), indicating a 100-fold higher viral load among IgG negative participants ( Figure 5 ).

Cases with a high viral load and a low or lacking IgG titer were presumably in an early phase of infection. In agreement with this, 10 of the 11 anti-spike IgG negative cases reported symptom onset less than 14 days (2-12 days) before blood sampling (Figure 4) .

To detect participants that may have recovered from COVID-19, antibody analysis was performed for all 77 PCR negative participants. Only one participant (from Asia) had both SARS-CoV-2 IgM and IgG, the latter detected by two assays (Figure 4) . In five others, only IgM or IgG antibodies against the spike-protein were detected. These six plasma samples were further analyzed by immunofluorescence staining of SARS-CoV-2 infected Vero cells. We concluded that only one PCR negative participant was seropositive for SARS-CoV-2, indicating prior COVID-19. Noteworthy, the two different IgM and IgG assays used gave identical qualitative results for 98% (112/114) and 94% (108/114) of samples ( Figure 3 ). The only other viruses belonging to this outbreak genetic group in Norway were viruses received in the National Reference Laboratory from non-participant crew members (n=5), cases among passengers (n=10) and their close contacts (n=2). Apart from these, the closest sequence matches were viruses mostly detected in India and Saudi Arabia in April 2020-February 2021. Within the outbreak cluster, further sub-grouping based on single nucleotide substitutions could be discerned.

The findings from the epidemiological, serological and WGS investigations are consistent with an evolving COVID-19 outbreak in this multinational, non-immune study population, caused by a single virus introduction that was identified in all cases with a successful WGS result. Efficient infection control measures were quickly implemented just after the ship's arrival in Tromsø and the outbreak was successfully contained.

We found that type of work, mechanical operations (i.e. engine work) and catering, were the main outbreak driver as also reported in other ship outbreaks (Expert Taskforce for the COVID-19 Cruise Ship Outbreak, 2020, Kakimoto et al., 2020 , Kasper et al., 2020 . The finding that sharing cabin with an infected cabin mate increased the odds for being a case is in line with a study among passengers aboard the Diamond Princess (Plucinski et al., 2021) . We detected only few cases among those with outdoor work reinforcing the evidence that SARS-CoV-2 transmission is lower outdoors (Bulfone et al., 2021 , Kasper et al., 2020 .

The increased odds for COVID-19 among Filipino participants was strongly attenuated in the multivariable analysis suggesting that workplace and sharing cabin were stronger risk factors than country of origin. This may reflect the segregated community on cruise ships with crew from low-income countries living in shared facilities and working in confined spaces making them more vulnerable to infections.

The outbreak was probably initiated by an Asian crew member prior to the first expedition and subsequently spread among crew and passengers on two expeditions in Arctic waters, illustrating how increased international mobility results in fast spread of infectious diseases.

Although no crew member participants reported symptom onset between 6-19 July, there was likely ongoing transmission during this period, either by unreported illness or asymptomatic SARS-CoV-2 transmission (Payne et al., 2020) . A non-participant crew member reported symptom onset on 6 July and could have been the primary case. The increasing number of cases from Expedition 1 to 2 shows that there was more extensive transmission on the second voyage with likely spill-over from crew to passengers. Given a typical incubation period of 4-5 days (Lauer et al., 2020) , this would suggest that exposure occurred simultaneously for many people on board. It is likely that breaches in several of the intended control measures led to undetected transmission onboard in early to mid-July while preparing for departure.

With the exception of five cases, all cases had detectable levels of SARS-CoV-2 specific IgM and/or IgG antibodies confirming their COVID-19 diagnosis. The measured antibody response seems to agree with other studies. SARS-CoV-2 IgM is usually detected by day 5-7 from symptom onset and IgG by day 7-10 with peak levels approximately day 49 (Stephens and McElrath, 2020) .

declines about 1000-fold within 10 days post-diagnosis, contemporary with an increasing level of SARS-CoV-2 antibodies (Cevik et al., 2021 , Leuzinger et al., 2021a , Leuzinger et al., 2021b . As our 10 IgG negative cases (five were also IgM negative), had median RNA load >100-fold higher than the 27 IgG positive cases, they were most likely in an early phase of infection. In agreement with this, 10 of the 11 cases that were lacking detectable IgG antibodies against the spike-protein, reported symptom onset only 2-12 days before sampling, giving us confidence in the retrospectively reported symptom data. SARS-CoV-2 IgM and IgG was only convincingly detected in one of 77 PCR negative participants, increasing the number of seropositive participants to 33. This may have been a crew member with infection prior to the outbreak or one of the first outbreak-cases.

In five other PCR-negative participants, single-assay positive anti-spike IgM or IgG results were likely due to cross-reactivity of pre-existing antibodies against seasonal coronavirus or other microbes, as previously described (Manthei et al., 2021) . Since only one PCR negative participants was seropositive, pre-existing SARS-CoV-2 immunity did probably not contribute to limit the spread of the virus. Instead, cross-reactive T cells from previous infections with common human coronaviruses (Perez-Potti et al., 2021) or a strong innate immune response (Park and Iwasaki, 2020) may have offered some protection.

The first documented COVID-19 case outside China was reported in Thailand mid-January 2020, only 6 months before Expedition 2. Using a combination of serology and PCR we assume to have detected all prior and ongoing SARS-CoV-2 infections among the participating crew. 

The strengths include the multidisciplinary approach generating detailed epidemiological data, and the inclusion of WGS data from most of the PCR positive participants. Our access to the National Reference Laboratory database enabled comparison of the outbreak strain to the Norwegian WGS database to map any onward transmission in Norway, which to our knowledge has not been done in previous studies. The study was limited by the fact that only three-quarters of crew members consented to participation, no passengers were included, and data on social gatherings were not available, implying potentially significant missing links for studying virus transmission dynamics. Furthermore, symptom onset dates were obtained retrospectively for the early cases, which may have introduced selection and recall bias, and immune response was measured only once.

We found that the combined use of epidemiology, serology and WGS can describe a SARS-CoV-2 outbreak in detail. The study is important in understanding the dynamics of an outbreak to prevent and control further outbreaks on cruise ships. The outbreak occurred early in the pandemic as one of the first reported on a Norwegian vessel. Norwegian legislation related to the COVID-19 pandemic has since been amended and national recommendations for coastal cruise vessels, including crew change, accordingly revised (Norwegian Maritime Authority, 2021). Current legislation and guidance explicitly state that cruise ship companies need to implement infection control measures as described in their Safety management system that includes risk assessment, responsibility, resources needed, and communication, education and test strategies, and this is in accordance with the European recommendations (ECDC, 2021).

KG, GSS, OK and PE designed the study. KG wrote the study protocol and applied for ethical approval. KG, SH and GSS contributed to the collection of blood samples. KG, KS and HS conducted the epidemiological analyses. SH and CHR conducted and interpreted the serological analyses. OH conducted the WGS sequence analysis. OH, KSJ and KB interpreted the WGS. KG and CHR drafted the manuscript. All authors contributed to interpreting the analysis, developing the manuscript and approving the final draft.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors. This work was not funded, and the authors' employers had no role in writing the manuscript or the decision to submit it for publication.

The study was approved by the Regional Committee for Medical and Health Research Ethics, North Norway (reference: 2020/170968) and the Data Protection Officer at UNN (2020/9635). The study complied with the Declaration of Helsinki. All participants signed an informed consent form prior to participation. a The colour codes correspond to the four clusters in the network analysis in Figure 2 . b A few European countries. c Administrative work: officers and managers. Passenger services: reception, store and medical/spa. Outdoor work: expedition team and work on deck. Mechanical operations: engine work, electricity, and carpentry. Catering: restaurant, bar and kitchen.

Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance : bulletin Europeen sur les maladies transmissibles

Corona Methods Development Community. nCoV-2019 sequencing protocol v3 (LoCost)

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Centre for Disease Prevention and Control. COVID-19: EU guidance for cruise ship operations

Expert Taskforce for the COVID-19 Cruise Ship Outbreak. Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama

The Global Initiative on Sharing All Influenza Data database 2021

Antibody response in a family with COVID-19. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin

Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship -Yokohama

An Outbreak of Covid-19 on an Aircraft Carrier

Systematic Review on Outbreaks of SARS-CoV-2 on Cruise, Navy and Cargo Ships

Molecular Evolutionary Genetics Analysis across Computing Platforms

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures

Comparing immunoassays for SARS-Coronavirus-2 antibody detection in patients with and without laboratory-confirmed SARS-Coronavirus-2 infection

Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples

Guidelines for crew changes in Norway during the COVID-19 pandemic

Type I and Type III Interferons -Induction, Signaling, Evasion, and Application to Combat COVID-19

SARS-CoV-2 Infections and Serologic Responses from a Sample of

Deciphering the ins and outs of SARS-CoV-2-specific T cells

COVID-19) in Americans Aboard the Diamond Princess Cruise Ship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of

COVID-19 and the Path to Immunity

SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship: A retrospective cohort study

Utbrudd av covid-19 på Hurtigruten-skipet MS Roald Amundsen 17.-31

The authors alone are responsible for the views expressed in this publication, and they do not necessarily represent the decisions or policies of their respective employers. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.The authors would also like to thank the following: All participants, technicians at the University Hospital of North Norway, and Norwegian Institute of Public Health who drew blood samples, performed SARS-CoV-2, PCR, serology and WGS, Kathrine Kristoffersen and Trond Brattland at the Public Health Department in Tromsø municipality, and originating and submitting laboratories that have provided the SARS-CoV-2 sequences in the GISAID EpiFlu database used in this analysis.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: